X4 Pharmaceuticals (XFOR) Change in Inventory (2024 - 2026)

X4 Pharmaceuticals (XFOR) has reported Change in Inventory for 3 consecutive years, with $865000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Inventory rose 967.9% year-over-year to $865000.0; the trailing twelve-month figure through Jun 2026 stood at $2.3 million (changed 0.3% YoY), and the FY2025 full-year result was $1.7 million, down 41.0% from the prior year.
• Change in Inventory advanced to $865000.0 in Q2 2026 per XFOR's latest filing, from $158000.0 in the prior quarter.
• Across five years, Change in Inventory topped out at $1.6 million in Q3 2024 and bottomed at $81000.0 in Q2 2025.
• Historically, Change in Inventory has averaged $611333.3 across 3 years, with a median of $399000.0 in 2025.
• The sharpest annual moves came in 2025 and 2026: Change in Inventory sank 90.25% in 2025, then soared 967.9% in 2026.
• Over 3 years, Change in Inventory stood at $372000.0 in 2024, then increased by 7.26% to $399000.0 in 2025, then jumped by 116.79% to $865000.0 in 2026.
• According to Business Quant data, Change in Inventory over the past three periods registered $865000.0, $158000.0, and $399000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.